Jayne B. Hart

Jayne B. Hart, listed as senior executive, appears in our data through filings on Myriad Genetics Inc shares, published by SEC (Form 4). In total, 15 filings cover trades dated from 28 May 2021 to 9 October 2022.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 11 October 2022, the filings show a share grant worth €40k in Myriad Genetics Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.